UniProt ID | PELI2_HUMAN | |
---|---|---|
UniProt AC | Q9HAT8 | |
Protein Name | E3 ubiquitin-protein ligase pellino homolog 2 | |
Gene Name | PELI2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 420 | |
Subcellular Localization | ||
Protein Description | E3 ubiquitin ligase catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins. Involved in the TLR and IL-1 signaling pathways via interaction with the complex containing IRAK kinases and TRAF6. Mediates IL1B-induced IRAK1 'Lys-63'-linked polyubiquitination and possibly 'Lys-48'-linked ubiquitination. May be important for LPS- and IL1B-induced MAP3K7-dependent, but not MAP3K3-dependent, NF-kappa-B activation. Can activate the MAP (mitogen activated protein) kinase pathway leading to activation of ELK1.. | |
Protein Sequence | MFSPGQEEHCAPNKEPVKYGELVVLGYNGALPNGDRGRRKSRFALYKRPKANGVKPSTVHVISTPQASKAISCKGQHSISYTLSRNQTVVVEYTHDKDTDMFQVGRSTESPIDFVVTDTISGSQNTDEAQITQSTISRFACRIVCDRNEPYTARIFAAGFDSSKNIFLGEKAAKWKNPDGHMDGLTTNGVLVMHPRGGFTEESQPGVWREISVCGDVYTLRETRSAQQRGKLVESETNVLQDGSLIDLCGATLLWRTADGLFHTPTQKHIEALRQEINAARPQCPVGLNTLAFPSINRKEVVEEKQPWAYLSCGHVHGYHNWGHRSDTEANERECPMCRTVGPYVPLWLGCEAGFYVDAGPPTHAFTPCGHVCSEKSAKYWSQIPLPHGTHAFHAACPFCATQLVGEQNCIKLIFQGPID | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MFSPGQEEHC -----CCCCCCCCCC | 27.16 | - | |
36 | Methylation | GALPNGDRGRRKSRF CCCCCCCCCCCCCCE | 41.75 | 81452627 | |
38 | Methylation | LPNGDRGRRKSRFAL CCCCCCCCCCCCEEE | 43.69 | 115388779 | |
47 | Ubiquitination | KSRFALYKRPKANGV CCCEEEECCCCCCCC | 64.17 | - | |
50 | Acetylation | FALYKRPKANGVKPS EEEECCCCCCCCCCC | 59.52 | 7965575 | |
55 | Acetylation | RPKANGVKPSTVHVI CCCCCCCCCCEEEEE | 34.35 | 7965585 | |
63 | Phosphorylation | PSTVHVISTPQASKA CCEEEEEECCCCCCC | 32.71 | 28555341 | |
64 | Phosphorylation | STVHVISTPQASKAI CEEEEEECCCCCCCC | 14.32 | - | |
69 | Ubiquitination | ISTPQASKAISCKGQ EECCCCCCCCCCCCE | 53.40 | - | |
74 | Ubiquitination | ASKAISCKGQHSISY CCCCCCCCCEEEEEE | 55.61 | - | |
78 | Phosphorylation | ISCKGQHSISYTLSR CCCCCEEEEEEEECC | 12.82 | 30576142 | |
80 | Phosphorylation | CKGQHSISYTLSRNQ CCCEEEEEEEECCCC | 18.32 | 30576142 | |
81 | Phosphorylation | KGQHSISYTLSRNQT CCEEEEEEEECCCCE | 15.27 | - | |
82 | Phosphorylation | GQHSISYTLSRNQTV CEEEEEEEECCCCEE | 16.09 | 30576142 | |
84 | Phosphorylation | HSISYTLSRNQTVVV EEEEEEECCCCEEEE | 22.76 | - | |
88 | Phosphorylation | YTLSRNQTVVVEYTH EEECCCCEEEEEEEC | 20.86 | 28555341 | |
151 | Phosphorylation | VCDRNEPYTARIFAA ECCCCCCEEEEEEEE | 13.57 | 25839225 | |
164 | Ubiquitination | AAGFDSSKNIFLGEK EEECCCCCCEECCHH | 59.00 | - | |
171 | Ubiquitination | KNIFLGEKAAKWKNP CCEECCHHHHCCCCC | 52.42 | - | |
176 | Acetylation | GEKAAKWKNPDGHMD CHHHHCCCCCCCCCC | 58.87 | 19608861 | |
219 | Phosphorylation | SVCGDVYTLRETRSA EEECCEEEHHHCCHH | 21.13 | 24719451 | |
235 | Phosphorylation | QRGKLVESETNVLQD HHCCEEECCCCCCCC | 42.09 | 29978859 | |
237 | Phosphorylation | GKLVESETNVLQDGS CCEEECCCCCCCCCC | 39.65 | 29978859 | |
244 | Phosphorylation | TNVLQDGSLIDLCGA CCCCCCCCCHHHCCC | 30.37 | 29978859 | |
252 | Phosphorylation | LIDLCGATLLWRTAD CHHHCCCEEEEECCC | 13.99 | 29978859 | |
257 | Phosphorylation | GATLLWRTADGLFHT CCEEEEECCCCCCCC | 19.95 | 29978859 | |
264 | Phosphorylation | TADGLFHTPTQKHIE CCCCCCCCCHHHHHH | 22.24 | 29978859 | |
266 | Phosphorylation | DGLFHTPTQKHIEAL CCCCCCCHHHHHHHH | 51.94 | 29978859 | |
268 | Ubiquitination | LFHTPTQKHIEALRQ CCCCCHHHHHHHHHH | 49.37 | - | |
290 | Phosphorylation | QCPVGLNTLAFPSIN CCCCCCCCEECCCCC | 25.22 | 30576142 | |
295 | Phosphorylation | LNTLAFPSINRKEVV CCCEECCCCCHHHHH | 26.49 | 30576142 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
290 | T | Phosphorylation | Kinase | IRAK1 | P51617 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PELI2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PELI2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
IRAK1_HUMAN | IRAK1 | physical | 17675297 | |
IRAK4_HUMAN | IRAK4 | physical | 12860405 | |
IRAK1_HUMAN | IRAK1 | physical | 12860405 | |
IRAK1_HUMAN | IRAK1 | physical | 15917247 | |
TRAF6_HUMAN | TRAF6 | physical | 12804775 | |
NR2C2_HUMAN | NR2C2 | physical | 12804775 | |
PICAL_HUMAN | PICALM | physical | 21988832 | |
THAP7_HUMAN | THAP7 | physical | 21988832 | |
IRAK1_HUMAN | IRAK1 | physical | 25027698 | |
UCRI_HUMAN | UQCRFS1 | physical | 25027698 | |
TRAF6_HUMAN | TRAF6 | physical | 25027698 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-176, AND MASS SPECTROMETRY. |